首页> 外文OA文献 >Once-daily simeprevir in combination with pegylated-interferon and ribavirin: a new horizon in the era of direct-acting antiviral agent therapy for chronic hepatitis C

【2h】

Once-daily simeprevir in combination with pegylated-interferon and ribavirin: a new horizon in the era of direct-acting antiviral agent therapy for chronic hepatitis C

机译：每日一次SimePrevir与Pegymated-Interferon和利巴韦林组合：一种新的耐催化剂治疗中的新地平线，慢性丙型肝炎

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Shinya Maekawa; Nobuyuki Enomoto;
展开▼
作者单位

展开▼
年度 2013
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Once-daily simeprevir in combination with pegylated-interferon and ribavirin: A new horizon in the era of direct-acting antiviral agent therapy for chronic hepatitis C [J] . MaekawaS., EnomotoN. Journal of gastroenterology . 2014,第1期

机译：每日一次的simeprevir与聚乙二醇化干扰素和利巴韦林联用：直接作用抗病毒药物治疗慢性丙型肝炎时代的新视野
2. Colitis during new direct-acting antiviral agents (DAAs) therapy with sofosbuvir, simeprevir and ribavirin for genotype 1b hepatitis C [J] . Izzo Ilaria, Zanotti Paola, Chirico Claudia, Infection . 2016,第6期

机译：索非布韦，西美派韦和利巴韦林在新的直接作用抗病毒药物（DAA）治疗中治疗基因型1b丙型肝炎时的结肠炎
3. Colitis during new direct-acting antiviral agents (DAAs) therapy with sofosbuvir, simeprevir and ribavirin for genotype 1b hepatitis C [J] . Izzo Ilaria, Zanotti Paola, Chirico Claudia, Infection . 2016,第6期

机译：结肠炎在新的直接作用抗病毒剂（DAAS）治疗中，SIMEPUVIR，SIMEPREVIR和Ribavirin进行基因型1B丙型肝炎
4. Studies of Therapy with Thymosin α 1 in Combination with Pegylated Interferon α2a and Ribavirin in Nonresponder Patients with Chronic Hepatitis C [C] . ROBERTO CAMERINI, ALESSIA CIANCIO, ALFONSO DE ROSA, International Symposiumn on Thymosins in Health and Disease; 20070321-24; Washington,DC(US) . 2007

机译：胸腺素α1联合聚乙二醇化干扰素α2a和利巴韦林治疗慢性丙型肝炎无反应者的研究
5. The meaning of adherence among veterans receiving pegylated interferon and ribavirin antiviral treatment for chronic hepatitis C. [D] . Phillips, Frances Hinshaw. 2011

机译：接受聚乙二醇干扰素和利巴韦林抗病毒治疗的慢性丙型肝炎退伍军人依从性的含义。
6. 4CPS-089 All-oral direct-acting antiviral combination therapy: chronic hepatitis c treatment after unsuccessful therapy with daas agents [O] . M Madrid Gonzalez, M Moreno-Garcia, JJ Castellano-Herrador, 2018

机译：4CPS-089全口服直效抗病毒组合治疗：慢性丙型肝炎治疗后的DAAS代理服用不成功治疗
7. A case report of psychiatric symptoms following direct-acting antiviral and ribavirin combination therapy for chronic hepatitis C in a patient with innate anxiety [O] . Akira Sakamaki, Kenya Kamimura, Naoki Fukui, 2019

机译：在患者患者中直接抗病毒性和利巴韦林联合治疗慢性丙基霉素组合治疗的案例报告
8. Guidance for Industry Chronic Hepatitis C Virus Infection: Developing Direct-Acting Antiviral Agents for Treatment [R] . 2010

机译：工业慢性丙型肝炎病毒感染指南：开发直接作用的抗病毒药物进行治疗

Once-daily simeprevir in combination with pegylated-interferon and ribavirin: a new horizon in the era of direct-acting antiviral agent therapy for chronic hepatitis C

著录项

引文网络

相似文献

相关主题

期刊订阅